0000950170-23-068894.txt : 20231207 0000950170-23-068894.hdr.sgml : 20231207 20231207200951 ACCESSION NUMBER: 0000950170-23-068894 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231207 DATE AS OF CHANGE: 20231207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 231473738 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Crowley John F CENTRAL INDEX KEY: 0001400973 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 144 1 primary_doc.xml 144 0001400973 XXXXXXXX LIVE 0001652130 Intellia Therapeutics, Inc. 001-37766 40 Erie Street Suite 130 Cambridge MA 02139 857-285-6200 John F. Crowley Former Director Common Stock E*Trade Financial Corporation

3 Edison Drive Alpharetta GA 30035

32791 506703.83 89554891 12/06/2023 NASDAQ Common Stock 12/06/2023 Option Exercise Issuer N 25500 12/06/2023 Cash Common Stock 06/14/2022 RSU Vesting Issuer N 2094 06/14/2022 N/A Common Stock 06/14/2023 RSU Vesting Issuer N 5197 06/14/2023 N/A Y 12/07/2023 /s/ John F. Crowley